ChargePoint Technology acquires PuroVaso for greater range of powder and liquid transfer solutions
ChargePoint Technology has acquired PuroVaso, leader in the design, development, and manufacture of single-use containers, handling equipment, and accessories for pharma, biopharma, and life sciences.
Powder and liquid transfer specialist ChargePoint Technology group have announced their acquisition of PuroVaso, a pharmaceutical product wholesaler of single-use containers, handling equipment, and accessories for the pharma, biopharma, and life sciences markets.
With the addition of PuroVaso to ChargePoint Technology’s portfolio of containment and sterile transfer technology, pharmaceutical manufacturers will have a greater range of powder and liquid transfer storage and handling products to choose from in order to satisfy application specific problems. ChargePoint Technology is a solution provider for powder containment and aseptic transfer valves, providing its customers with operator safety and sterility assurance in the pharmaceutical, biotech, chemical, and process industries.
CEO of ChargePoint Technology Chris Eccles stated: “PuroVaso has vast technical expertise in pharmaceutical processing, transfer, handling, and storage with a broad portfolio of products that customers rely on for critical process applications… With its extensive process knowledge, application engineered solutions, and relentless customer focus, PuroVaso offers leading solutions to highly regulated pharma and biopharma landscapes along with several other process critical markets. We are very excited to have PuroVaso join the ChargePoint portfolio of solutions.”
Additionally, Steve Boswell, Co-Founder and Director of PuroVaso, commented: “We are very proud to have developed a handling solution that provides an altogether improved and sustainable approach to handling powders. Now is the time to allow the PuroVaso product line to reach its true potential with Chargepoint.
Related News
-
News Women in Pharma: Moving beyond discussions and into best practice at CPHI Milan
In this second CPHI Milan special of our monthly series, we cover the key takeaways from the Diversity & Wellbeing track held on October 10, 2024. -
News AstraZeneca invests in AI collaboration for cancer drug trials
The British-Swedish pharmaceutical giant is partnering with biotechnology firm Immunai Inc to increase the efficiency of some cancer drug trials. -
News Ozempic and Wegovy prices questioned as Novo Nordisk faces US Senate hearing
The CEO of Novo Nordisk was grilled during a US Senate committee hearing on September 24, 2024, in which the exorbitant prices of the Danish company’s blockbuster drugs Ozempic and Wegovy were called into question. -
News The BIOSECURE Act: implications for the pharma supply chain
On September 9, 2024, the US House of Representatives voted to pass the bill titled the BIOSECURE Act (the Act), which lists several Chinese companies in the pharmaceutical supply chain. The Act will prohibit American companies from contracting or doin... -
News On Track at CPHI Milan: Thermo Fisher Scientific Track Sponsor interview
With CPHI Milan just around the corner, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma. -
News CPHI Milan Speaker Spotlight: Pharma Manufacturing and Localisation in Africa
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Eli Lilly licenses rheumatoid arthritis manufacturing in Africa
American pharmaceutical company Eli Lilly has signed a partnership with Egyptian organisation Eva Pharma to localise manufacturing of rheumatoid arthritis treatments in Africa.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance